Cargando…

WCN23-1238 COMORBIDITIES ASSOCIATED WITH INCREASED RISK OF DEATH IN CKD PATIENTS WITH COVID-19

Detalles Bibliográficos
Autores principales:	BRAZ, B., Fernandes de Souza Mourão feitosa, A., de Carvalho Sobreira, J.N., Andreazza Machado, G., Holanda de Morais Pinho, H., Cavalcante Meneses, G., Bezerra da Silva Junior, G., de Francesco Daher, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Covid-19 and CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025625/ http://dx.doi.org/10.1016/j.ekir.2023.02.1020

Ejemplares similares

WCN23-1183 DISPARITIES IN CHRONIC KIDNEY DISEASE RISKS: DATA FROM THE CURE-CKD COVID-19 REGISTRY
por: Nicholas, S., et al.
Publicado: (2023)

WCN23-0981 RISK FACTORS FOR COVID-19 MORTALITY IN HEMODIALYSIS PATIENTS
por: TOMANOSKI, V., et al.
Publicado: (2023)

WCN23-0651 LONG-TERM EFFECTIVENESS OF COVID-19 VACCINE AMONG DIALYSIS PATIENTS
por: Rosa Diez, G., et al.
Publicado: (2023)

WCN23-0430 PREDICTORS FOR FAILURE REDUCTION OF HEMODIALYSIS FREQUENCY DURING THE PANDEMIC
por: Pattharanitima, P., et al.
Publicado: (2023)

WCN23-0345 EFFECTIVENESS OF COVID-19 VACCINE IN PATIENT UNDERGOING HEMODIALYSIS
por: FATIMAH, S., et al.
Publicado: (2023)

WCN23-0655 INCIDENCE AND OUTCOMES OF COVID-19 IN DIALYSIS PATIENTS. DATA FROM THE ARGENTINE REGISTRY OF CHRONIC DIALYSIS
por: Bisigniano, L., et al.
Publicado: (2023)

WCN23-0519 VACCINE RESPONSE AGAINST SARS-Cov-2 AMONG HEMODIALYSIS PATIENTS IN TWO SENEGALESE CENTERS IN 2021
por: MOTOULA LATOU, L.N.P., et al.
Publicado: (2023)

WCN23-0825 TELENEPHROLOGY: MANAGING CHRONIC KIDNEY DISEASE DURING COVID-19 PANDEMIC
por: Sharma, S.K., et al.
Publicado: (2023)

WCN23-0616 SARS-COV-2 INFECTION AMONG HOSPITALIZED PATIENTS WITH CHRONIC KIDNEY DISEASE
por: Munaa, B., et al.
Publicado: (2023)

WCN23-1019 CUMULATIVE INCIDENCE OF COVID-19 AND VACCINE PROFILES AMONG ASEAN PERITONEAL DIALYSIS POPULATIONS: A PRELIMINARY RESULT OF THE "InCoV-PD" STUDY GROUP
por: Mushahar, L., et al.
Publicado: (2023)

WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
por: Stepanova MD, N., et al.
Publicado: (2023)

WCN23-0389 ASSOCIATED FACTORS TO CLINICAL OUTCOMES OF COVID-19 AMONG HOSPITALIZED PATIENTS UNDERGOING MAINTENANCE DIALYSIS
por: MEDRIANO, R., et al.
Publicado: (2023)

WCN23-0938 IMPACT OF THE COVID-19 PANDEMIC IN PATIENTS ATTENDING RENAL CLINIC AT KINGSTON PUBLIC HOSPITAL, JAMAICA
por: DEWAR, D., et al.
Publicado: (2023)

WCN23-0787 A CASE OF IGA VASCULITIS THAT DEVELOPED GROSS HEMATURIA AND LOWER-LIMB PURPURA FOLLOWING COVID-19 VACCINES
por: MORI, K., et al.
Publicado: (2023)

WCN23-1086 ACUTE KIDNEY INJURY AFTER COVID 19 INFECTION IN CHRONIC KIDNEY DISEASE PATIENTS OF BANGLADESH: RETROSPECTIVE STUDY
por: NOBI, F., et al.
Publicado: (2023)

WCN23-0291 USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEIs) AND ANGIOTENSIN-RECEPTOR BLOCKERS (ARBs) AND INCIDENCE OF PNEUMONIA OR INFLUENZA OR COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Qin, X., et al.
Publicado: (2023)

WCN23-0120 MEDIUM AND LONG TERM ANTIBODY RESPONSE TO COVID-19 VACCINATION IN PATIENTS RECEIVING HEMODIALYSIS (HD) - A CROSS SECTIONAL STUDY
por: Cheema, S., et al.
Publicado: (2023)

WCN23-0886 CONTRIBUTION TO THE STUDY OF ADVERSE EVENTS FOLLOWING VACCINATION AGAINST COVID-19 IN CHRONIC HEMODIALYSIS PATIENTS IN SENEGAL: A REVIEW OF 367 CASES
por: SARR, I., et al.
Publicado: (2023)

WCN23-0544 CLINICAL PROFILE, IMMUNOSUPPRESSIVE MANAGMENT AND OUTCOME IN ADULT RENAL ALLOGRAFT RECIPIENTS WITH COVID-19 INFECTION: A CASE SERIES FROM SINGLE CENTRE IN BANGLADESH
por: MAHJABIN, S., et al.
Publicado: (2023)

WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS
por: KLOCHKOVA, N., et al.
Publicado: (2023)

WCN23-1093 First report of durability of antibody response in maintenance haemodialysis patients and kidney transplant recipients vaccinated with ChAdOx1 nCoV-19 vaccine: A prospective, multicentre, observational, study
por: CHAUHAN, S.
Publicado: (2023)

WCN23-0100 ENDOTHELIAL BIOMARKERS IN CRITICALLY ILL PATIENTS WITH COVID-19: POTENTIAL PREDICTORS OF THE NEED FOR DIALYSIS
por: Cavalcante Meneses, G., et al.
Publicado: (2023)

WCN23-0333 THE FREQUENCY OF DYSNATREMIA IN PATIENTS ADMITTED WITH COVID-19 INFECTION
por: KHAN, F.G., et al.
Publicado: (2023)

WCN23-0624 ACUTE KIDNEY INJURY AND COVID-19
por: JERNDAL, H., et al.
Publicado: (2023)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

WCN23-0857 Utility of urinary biomarkers for diagnosis of acute kidney injury (AKI) in COVID-19
por: SAMRA, T., et al.
Publicado: (2023)

WCN23-0316 COVID-19 VACCINATION INDUCED MINIMAL CHANGED DISEASE
por: ALKANDARI, N., et al.
Publicado: (2023)

WCN23-0601 MORTALITY OF PATIENTS WITH CKD AND ITs RISK FACTORS ADMITTED TO HOSPITAL WITH COVID-19 IN ALMATY CITY KAZAKHSTAN BETWEEN 2020-2022
por: GARAZHAYEVA, L., et al.
Publicado: (2023)

Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients
por: Cianciolo, Giuseppe, et al.
Publicado: (2016)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary
por: Pippias, Maria, et al.
Publicado: (2017)

WCN23-1131 RISK OF AKI IN COVID-19 PATIENTS: CLINICAL COURSE AND OUTCOMES
por: Flores Fonseca MD, M.M., et al.
Publicado: (2023)

WCN23-0312 THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR AND OTHER URINARY CYTOKINES SINCE SUBCLINICAL AKI IN PATIENTS WITH COVID-19
por: CASAS, G., et al.
Publicado: (2023)

Anticoagulant-related nephropathy: systematic review and meta-analysis
por: de Aquino Moura, Karolinny Borinelli, et al.
Publicado: (2019)

Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease
por: van der Vorm, Lisa N, et al.
Publicado: (2019)

Obesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
por: Barbieri, Diego, et al.
Publicado: (2018)

WCN23-1216 KIDNEY BIOPSIES DURING THE COVID-19 OUTBREAK: A SERIES OF CASES
por: Pantaleon, H., et al.
Publicado: (2023)

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
por: Brown, Stephanie A, et al.
Publicado: (2017)

WCN23-0213 PROXIMAL TUBULAR DYSFUNCTION AS A PREDICTOR OF AKI IN HOSPITALIZED COVID-19 PATIENTS
por: ALIMUL BARI, A., et al.
Publicado: (2023)

WCN23-0071 CYTOKINE ADSORBING COLUMN IN SEVERE COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY
por: Madhyastha, P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j5q6ga80bvllm766a7j39lcr13